A pathogenic role for CD8+ T cells in a spontaneous model of demyelinating disease

Journal of Immunology

Volumn 177, Issue 4, 2006, Pages 2403-2411

  Brisebois, Marcel ^a   Zehntner, Simone P ^a   Estrada, José ^a   Owens, Trevor ^a   Fournier, Sylvie ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON RECEPTOR; LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; INFLAMMATORY INFILTRATE; LYMPHOID ORGAN; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

EID: 33746896222     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.4.2403     Document Type: Article

References (64)

1. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-684.
2. Ben-Nun, A., H. Wekerle, and I. R. Cohen. 1981. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11: 195-199.
3. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25: 1951-1959.
4. Yoshimura, T., T. Kunishita, K. Sakai, M. Endoh, T. Namikawa, and T. Tabira. 1985. Chronic experimental allergic encephalomyelitis in guinea pigs induced by proteolipid protein. J. Neurol. Sci. 69: 47-58.
5. + T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. USA 91: 10859-10863.
6. + cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism. J Neuroimmunol. 73: 7-14.
7. Dressel, A., J. L. Chin, A. Sette, R. Gausling, P. Hollsberg, and D. A. Hafler. 1997. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands. J. Immunol. 159: 4943-4951.
8. + T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103: 4222-4231.
9. + T cells are correlated to MRI features of tissue destruction in MS. J. Neuroimmunol. 142: 141-148.
10. + T cells in multiple sclerosis. Autoimmunity 23: 127-138.
11. + T cells in cerebrospinal fluid from multiple sclerosis patients Brain 125: 538-550.
12. Laplaud, D. A., C. Ruiz, S. Wiertlewski, S. Brouard, L. Berthelot, M. Guillet, B. Melchior, N. Degauque, G. Edan, P. Brachet, et al. 2004. Blood T-cell receptor β chain transcriptome in multiple sclerosis: characterization of the T cells with altered CDR3 length distribution. Brain 127: 981-995.
13. + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192: 393-404.
14. Albert, M. L., J. C. Darnell, A. Bender, L. M. Francisco, N. Bhardwaj, and R. B. Darnell. 1998. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat. Med. 4: 1321-1324.
15. Bien, C. G., J. Bauer, T. L. Deckwerth, H. Wiendl, M. Deckert, O. D. Wiestler, J. Schramm, C. E. Elger, and H. Lassmann. 2002. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis Ann. Neurol. 51: 311-318.
16. Sindern, E., C. Oreja-Guevara, M. Raulf-Heimsoth, X. Baur, and J. P. Malin. 1997. A longitudinal study of circulating lymphocyte subsets in the peripheral blood during the acute stage of Guillain-Barre syndrome. J. Neurol. Sci. 151: 29-34.
17. Tanaka, M., K. Tanaka, S. Tokiguchi, K. Shinozawa, and S. Tsuji. 1999. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody. J. Neurol Sci. 168: 28-31.
18. Van den Berg, L. H., I. Mollee, J. H. Wokke, and T. Logtenberg. 1995. Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases. J. Neuroimmunol. 58: 37-42.
19. Sun, D., Y. Qin, J. Chluba, J. T. Epplen, and H. Wekerle. 1988. Suppression of experimentally induced autoimmune encephalomyelitis by cytolylic T-T cell interactions. Nature 332: 843-845.
20. Miller, A., O. Lider, A. B. Roberts, M. B. Sporn, and H. L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89: 421-425.
21. + T cells in EAE mice. Proc. Natl. Acad. Sci. USA 98: 6301-6306.
22. + T cells fine-tune the myelin basic protein-reactive T cell receptor Vβ repertoire during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 100: 8378-8383.
23. + CD28 T cells in an autoimmune disease model. J. Clin. Invest. 112: 1037-1048.
24. -/- DBA/1 mice defines qualitative roles of different T cell subsets. J. Neuroimmunol. 141: 10-19.
25. + T cells in a model for multiple sclerosis. J. Exp. Med. 194: 669-676.
26. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166: 7579-7587.
27. + T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35: 76-85.
28. Zehntner, S. P., M. Brisebois, E. Tran, T. Owens, and S. Fournier. 2003. Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease. FASEB J. 17: 1910-1912.
29. Fournier, S., J. C. Rathmell, C. C. Goodnow, and J. P. Allison. 1997. T cell-mediated elimination of B7.2 transgenic B cells. Immunity 6: 327-339.
30. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zoller, and P. Kourilsky, 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 90: 4319-4323.
31. + T cells in major histocompatibility complex class II-deficient mice. Science 253: 1417-1420.
32. Nguyen, K. B., and M. P. Pender. 1999. Survival and mitosis of myelinating oligodendrocytes in experimental autoimmune encephalomyelitis: an immunocytochemical study with Rip antibody. Acta Neuropathol. 98: 39-47.
33. Pitt, D., P. Werner, and C. S. Raine. 2000. Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6: 67-70.
34. Werner, P., D. Pitt, and C. S. Raine. 2001. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50: 169-180.
35. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
36. Heppner, F. L., M. Greter, D. Marino, J. Falsig, G. Raivich, N. Hovelmeyer, A. Waisman, T. Rulicke, M. Prinz, J. Priller, et al. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11: 146-152.
37. Rock, R. B., G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson. 2004. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 17:942-964.
38. Dasgupta, S., M. Jana, X. Liu, and K. Pahan. 2003. Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflanimatory cytokines in microglial cells. J. Biol. Chem. 278: 22424-22431.
39. Hickey, W. F. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36: 118-124.
40. Yu, X., S. Fournier, J. P. Allison, A. H. Sharpe, and R. J. Hodes. 2000. The role of B7 costimulation in CD4/CD8 T cell homeostasis. J. Immunol. 164: 3543-3553.
41. Neumann, H., I. M. Medana, J. Bauer, and H. Lassmann. 2002. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25: 313-319.
42. Steinman, L. 2001. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194: F27-F30.
43. + T cells in multiple sclerosis: a new target for therapy? Brain 128: 1747-1763.
44. Jiang, H., and L. Chess. 2004. An integrated view of suppressor T cell subsets in immunoregulation. J. Clin. Invest. 114: 1198-1208.
45. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA 100: 10878-10883.
46. Flugel, A., T. Berkowicz, T. Ritter, M. Labeur, D. E. Jenne, Z. Li, J. W. Ellwart, M. Willem, H. Lassmann, and H. Wekerle. 2001. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14: 547-560.
47. b mice. Eur. J. Immunol. 26: 2470-2479.
48. DiLorenzo, T. P., R. T. Graser, T. Ono, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze. 1998. Major histocompatibility complex class 1-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95: 12538-12543.
49. Bousso, P., A. Casrouge, J. D. Altman, M. Haury, J. Kanellopoulos, J. P. Abastado, and P. Kourilsky. 1998. Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires. Immunity 9: 169-178.
50. Pewe, L. L., J. M. Netland, S. B. Heard, and S. Perlman. 2004. Very diverse CD8 T cell clonotypic responses after virus infections. J. Immunol. 172: 3151-3156.
51. Shanmugam. A., C. Copie-Bergman, B. Falissard, O. Delrieu, J. P. Jais, D. Rebibo, J. F. Bach, and E. Tournier-Lasserve. 1996. TCR αβ gene usage for myelin basic protein recognition in healthy monozygous twins. J. Immunol. 156: 3747-3754.
52. + T cells into the central nervous system by professional antigen-presenting cells. Am. J. Pathol. 154: 481-494.
53. Krakowski, M. L., and T. Owens. 2000. Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation. Eur. J. Immunol. 30: 1002-1009.
54. Fritz, R. B., X. D. Wang, and M. L. Zhao. 2000. Alterations in the spinal cord T cell repertoire during relapsing experimental autoimmune encephalomyelitis. J. Immunol. 164: 6662-6668.
55. Chen, A. M., N. Khanna, S. A. Stohlman, and C. C. Bergmann. 2005. Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomy-elitis. J. Virol. 79: 4700-4708.
56. Ackerman, A. L., and P. Cresswell. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5: 678-684.
57. Nimmerjahn, A., F. Kirchhoff, and F. Helmchen. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318.
58. Pewe, L., and S. Perlman. 2002. Cutting edge: CD8 T cell-mediated demyelination is IFN-γ dependent in mice infected with a neurotropic coronavirus. J. Immunol. 168: 1547-1551.
59. Krakowski, M., and T. Owens. 1996. Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26: 1641-1646.
60. Panitch, H. S., R. L. Hirsch, J. Schindler, and K. P. Johnson. 1987. Treatment of multiple sclerosis with γ interferon: exacerbations associated with activation of the immune system. Neurology 37: 1097-1102.
61. Skurkovich, S., A. Boiko, I. Beliaeva, A. Buglak, T. Alekseeva, N. Smirnova, O. Kulakova, V. Tchechonin, O. Gurova, T. Deomina, et al. 2001. Randomized study of antibodies to IFN-γ and TNF-α in secondary progressive multiple sclerosis. Mult. Scler. 7: 277-284.
62. Smith, K. J., and H. Lassmann. 2002. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1: 232-241.
63. Jurewicz, A., W. E. Biddison, and J. P. Antel. 1998. MHC class 1-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J. Immunol. 160: 3056-3059.
64. Medana, I., M. A. Martinic, H. Wekerle, and H. Neumann. 2001. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am. J. Pathol. 159: 809-815.